Dow Inc (DOW)
NYSE: DOW · Chemicals · Midland, MI
Our rating: Cautious
Cautious reaffirmed at $33.99, moderate conviction, October 26, 2026.
Breaks if: The Cautious view would be wrong if Dow reports two consecutive quarters of positive diluted EPS alongside flat-to-positive revenue growth year-over-year — that combination would indicate a genuine cycle turn and prompt a reassessment toward Neutral. A price move above $42 without accompanying improvement in the earnings line would similarly signal the market is pricing in a recovery not yet visible in the filings.
Key figures
| Market value | $21.0B |
|---|---|
| Revenue, last 12 months | n/a |
| Net income, last 12 months | n/a |
| Free cash flow, last 12 months | n/a |
| Price to earnings | n/a |
| Free cash flow yield | n/a |
| Dividend yield | 4.8% |
| Operating margin | n/a |
| Return on equity | n/a |
| Beta to the S&P 500 | 0.79 |
| Volatility, annualized | 41.5% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $11.3B | 13.0% | $0.62 | n/a |
| March 31, 2026 | $9.8B | −6.1% | $-0.74 | $621M |
| December 31, 2025 | $9.5B | −9.1% | $-2.17 | −$284M |
| September 30, 2025 | $10.0B | −8.3% | $0.08 | $563M |
| June 30, 2025 | $10.1B | −7.4% | $-1.18 | −$1.1B |
| March 31, 2025 | $10.4B | −3.1% | $-0.44 | −$594M |
| December 31, 2024 | $10.4B | −2.0% | $-0.08 | $47M |
| September 30, 2024 | $10.9B | 1.4% | $0.30 | $64M |
11 ledger entries and 23 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.